Top compounds associated with response to FTO


Feature Type Standardized
Nominal ANOVA
mRNA isoliquiritigenin CTRPv2 pan-cancer AAC 0.034 0.6
mRNA narciclasine CTRPv2 pan-cancer AAC -0.016 0.6
mRNA MGCD-265 CTRPv2 pan-cancer AAC 0.016 0.6
mRNA JW-74 CTRPv2 pan-cancer AAC -0.021 0.6
mRNA marinopyrrole A CTRPv2 pan-cancer AAC 0.02 0.6
mRNA tivozanib GDSC1000 pan-cancer AAC -0.017 0.6
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.6
mRNA Crizotinib GDSC1000 pan-cancer AAC 0.026 0.6
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.051 0.6
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC 0.018 0.6
Download CSV